UVA1 phototherapy for cutaneous diseases: An experience of 92 cases in the United States

Chanisada Tuchinda; Holly A. Kerr; Charles R. Taylor; Heidi Jacobe; Bettany M. Bergamo; Craig Elmets; Jennifer Rivard; Henry W. Lim

doi:10.1111/j.1600-0781.2006.00245.x

UVA1 phototherapy for cutaneous diseases: An experience of 92 cases in the United States

Chanisada Tuchinda, Holly A. Kerr, Charles R. Taylor, Heidi Jacobe, Bettany M. Bergamo, Craig Elmets, Jennifer Rivard, Henry W. Lim

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Abstract

Background: The efficacy and safety of UVA1 (340-400nm) phototherapy were established by studies from European countries. Purpose: Evaluate experience with UVA1 phototherapy for patients with cutaneous diseases in the United States. Methods: A retrospective analysis of 92 cases of UVA1-treated cutaneous conditions from four medical centers in the United States was performed. Results: Two-third of the patients showed a fair to good response (26-100% improvement) and one-third of the patients showed a poor response (0-25% improvement). Diseases with a moderate to good response (51-100% improvement) included scleredema adultorum, hand or foot dermatitis, atopic dermatitis, morphea (medium or medium- to high-dose UVA1), systemic sclerosis, and urticaria pigmentosa. Besides tanning, other adverse effects were found in 15% of patients, which include pruritus, erythema, tenderness, and burning sensation. Patients with skin types I-III responded better that those with a darker skin type. Conclusion: UVA1 phototherapy is a useful and well-tolerated treatment option for a variety of skin conditions.

Original language	English (US)
Pages (from-to)	247-253
Number of pages	7
Journal	Photodermatology Photoimmunology and Photomedicine
Volume	22
Issue number	5
DOIs	https://doi.org/10.1111/j.1600-0781.2006.00245.x
State	Published - Oct 2006

Keywords

Ohototherapy
UVA1

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Radiology Nuclear Medicine and imaging
Dermatology

Access to Document

10.1111/j.1600-0781.2006.00245.x

Cite this

@article{3e3f3607c2ed416b91949657280ab25f,

title = "UVA1 phototherapy for cutaneous diseases: An experience of 92 cases in the United States",

abstract = "Background: The efficacy and safety of UVA1 (340-400nm) phototherapy were established by studies from European countries. Purpose: Evaluate experience with UVA1 phototherapy for patients with cutaneous diseases in the United States. Methods: A retrospective analysis of 92 cases of UVA1-treated cutaneous conditions from four medical centers in the United States was performed. Results: Two-third of the patients showed a fair to good response (26-100% improvement) and one-third of the patients showed a poor response (0-25% improvement). Diseases with a moderate to good response (51-100% improvement) included scleredema adultorum, hand or foot dermatitis, atopic dermatitis, morphea (medium or medium- to high-dose UVA1), systemic sclerosis, and urticaria pigmentosa. Besides tanning, other adverse effects were found in 15% of patients, which include pruritus, erythema, tenderness, and burning sensation. Patients with skin types I-III responded better that those with a darker skin type. Conclusion: UVA1 phototherapy is a useful and well-tolerated treatment option for a variety of skin conditions.",

keywords = "Ohototherapy, UVA1",

author = "Chanisada Tuchinda and Kerr, {Holly A.} and Taylor, {Charles R.} and Heidi Jacobe and Bergamo, {Bettany M.} and Craig Elmets and Jennifer Rivard and Lim, {Henry W.}",

year = "2006",

month = oct,

doi = "10.1111/j.1600-0781.2006.00245.x",

language = "English (US)",

volume = "22",

pages = "247--253",

journal = "Photodermatology Photoimmunology and Photomedicine",

issn = "0905-4383",

publisher = "Blackwell Munksgaard",

number = "5",

}

TY - JOUR

T1 - UVA1 phototherapy for cutaneous diseases

T2 - An experience of 92 cases in the United States

AU - Tuchinda, Chanisada

AU - Kerr, Holly A.

AU - Taylor, Charles R.

AU - Jacobe, Heidi

AU - Bergamo, Bettany M.

AU - Elmets, Craig

AU - Rivard, Jennifer

AU - Lim, Henry W.

PY - 2006/10

Y1 - 2006/10

N2 - Background: The efficacy and safety of UVA1 (340-400nm) phototherapy were established by studies from European countries. Purpose: Evaluate experience with UVA1 phototherapy for patients with cutaneous diseases in the United States. Methods: A retrospective analysis of 92 cases of UVA1-treated cutaneous conditions from four medical centers in the United States was performed. Results: Two-third of the patients showed a fair to good response (26-100% improvement) and one-third of the patients showed a poor response (0-25% improvement). Diseases with a moderate to good response (51-100% improvement) included scleredema adultorum, hand or foot dermatitis, atopic dermatitis, morphea (medium or medium- to high-dose UVA1), systemic sclerosis, and urticaria pigmentosa. Besides tanning, other adverse effects were found in 15% of patients, which include pruritus, erythema, tenderness, and burning sensation. Patients with skin types I-III responded better that those with a darker skin type. Conclusion: UVA1 phototherapy is a useful and well-tolerated treatment option for a variety of skin conditions.

AB - Background: The efficacy and safety of UVA1 (340-400nm) phototherapy were established by studies from European countries. Purpose: Evaluate experience with UVA1 phototherapy for patients with cutaneous diseases in the United States. Methods: A retrospective analysis of 92 cases of UVA1-treated cutaneous conditions from four medical centers in the United States was performed. Results: Two-third of the patients showed a fair to good response (26-100% improvement) and one-third of the patients showed a poor response (0-25% improvement). Diseases with a moderate to good response (51-100% improvement) included scleredema adultorum, hand or foot dermatitis, atopic dermatitis, morphea (medium or medium- to high-dose UVA1), systemic sclerosis, and urticaria pigmentosa. Besides tanning, other adverse effects were found in 15% of patients, which include pruritus, erythema, tenderness, and burning sensation. Patients with skin types I-III responded better that those with a darker skin type. Conclusion: UVA1 phototherapy is a useful and well-tolerated treatment option for a variety of skin conditions.

KW - Ohototherapy

KW - UVA1

UR - http://www.scopus.com/inward/record.url?scp=33748285230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748285230&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0781.2006.00245.x

DO - 10.1111/j.1600-0781.2006.00245.x

M3 - Article

C2 - 16948826

AN - SCOPUS:33748285230

SN - 0905-4383

VL - 22

SP - 247

EP - 253

JO - Photodermatology Photoimmunology and Photomedicine

JF - Photodermatology Photoimmunology and Photomedicine

IS - 5

ER -

UVA1 phototherapy for cutaneous diseases: An experience of 92 cases in the United States

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this